APO Research
Talk to an analyst

APO RESEARCH · REPORT

Butorphanol

Compare research editions
View pricing & licenses

Selected research

Industry Research

Butorphanol Industry Research Report 2026

19 December 2025137 pages

Choose your research edition.

Industry ResearchButorphanol Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Butorphanol Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Butorphanol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Butorphanol Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Butorphanol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Butorphanol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Butorphanol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Butorphanol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Butorphanol include Zoetis, Merck KGaA, Mylan, Pfizer, Troy Laboratories Nz, Selectavet, Sanochemia Pharmazeutika, Richter Pharma Ag and Novex Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Butorphanol market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Butorphanol Market by Company

Zoetis

Merck KGaA

Mylan

Pfizer

Troy Laboratories Nz

Selectavet

Sanochemia Pharmazeutika

Richter Pharma Ag

Novex Pharma

Hikma Pharmaceuticals

Faunapharma

Dechra Pharmaceuticals

Bristol Myers Squibb

Boehringer Ingelheim Santé Animale

Ausrichter

Athanas Enterprise Private Limited

Apothecon Pharmaceuticals

Animedica

Butorphanol Segment by Type

Injection

Spray

Tablet

Butorphanol Segment by Application

Human

Veterinary

Butorphanol Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Butorphanol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Butorphanol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Butorphanol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Butorphanol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Butorphanol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Butorphanol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Butorphanol Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Butorphanol Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Butorphanol Sales Market Share by Manufacturers (2021-2026) Table 8. Global Butorphanol Revenue of Manufacturers (2021-2026) Table 9. Global Butorphanol Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Butorphanol Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Butorphanol Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Butorphanol, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Butorphanol, Product Type & Application Table 14. Global Butorphanol Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Butorphanol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zoetis Butorphanol Product Portfolio Table 22. Zoetis Recent Developments Table 23. Merck KGaA Company Information Table 24. Merck KGaA Business Overview Table 25. Merck KGaA Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Merck KGaA Butorphanol Product Portfolio Table 27. Merck KGaA Recent Developments Table 28. Mylan Company Information Table 29. Mylan Business Overview Table 30. Mylan Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Mylan Butorphanol Product Portfolio Table 32. Mylan Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Pfizer Butorphanol Product Portfolio Table 37. Pfizer Recent Developments Table 38. Troy Laboratories Nz Company Information Table 39. Troy Laboratories Nz Business Overview Table 40. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Troy Laboratories Nz Butorphanol Product Portfolio Table 42. Troy Laboratories Nz Recent Developments Table 43. Selectavet Company Information Table 44. Selectavet Business Overview Table 45. Selectavet Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Selectavet Butorphanol Product Portfolio Table 47. Selectavet Recent Developments Table 48. Sanochemia Pharmazeutika Company Information Table 49. Sanochemia Pharmazeutika Business Overview Table 50. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Sanochemia Pharmazeutika Butorphanol Product Portfolio Table 52. Sanochemia Pharmazeutika Recent Developments Table 53. Richter Pharma Ag Company Information Table 54. Richter Pharma Ag Business Overview Table 55. Richter Pharma Ag Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Richter Pharma Ag Butorphanol Product Portfolio Table 57. Richter Pharma Ag Recent Developments Table 58. Novex Pharma Company Information Table 59. Novex Pharma Business Overview Table 60. Novex Pharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Novex Pharma Butorphanol Product Portfolio Table 62. Novex Pharma Recent Developments Table 63. Hikma Pharmaceuticals Company Information Table 64. Hikma Pharmaceuticals Business Overview Table 65. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hikma Pharmaceuticals Butorphanol Product Portfolio Table 67. Hikma Pharmaceuticals Recent Developments Table 68. Faunapharma Company Information Table 69. Faunapharma Business Overview Table 70. Faunapharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Faunapharma Butorphanol Product Portfolio Table 72. Faunapharma Recent Developments Table 73. Dechra Pharmaceuticals Company Information Table 74. Dechra Pharmaceuticals Business Overview Table 75. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Dechra Pharmaceuticals Butorphanol Product Portfolio Table 77. Dechra Pharmaceuticals Recent Developments Table 78. Bristol Myers Squibb Company Information Table 79. Bristol Myers Squibb Business Overview Table 80. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bristol Myers Squibb Butorphanol Product Portfolio Table 82. Bristol Myers Squibb Recent Developments Table 83. Boehringer Ingelheim Santé Animale Company Information Table 84. Boehringer Ingelheim Santé Animale Business Overview Table 85. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio Table 87. Boehringer Ingelheim Santé Animale Recent Developments Table 88. Ausrichter Company Information Table 89. Ausrichter Business Overview Table 90. Ausrichter Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ausrichter Butorphanol Product Portfolio Table 92. Ausrichter Recent Developments Table 93. Athanas Enterprise Private Limited Company Information Table 94. Athanas Enterprise Private Limited Business Overview Table 95. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Athanas Enterprise Private Limited Butorphanol Product Portfolio Table 97. Athanas Enterprise Private Limited Recent Developments Table 98. Apothecon Pharmaceuticals Company Information Table 99. Apothecon Pharmaceuticals Business Overview Table 100. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Apothecon Pharmaceuticals Butorphanol Product Portfolio Table 102. Apothecon Pharmaceuticals Recent Developments Table 103. Animedica Company Information Table 104. Animedica Business Overview Table 105. Animedica Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Animedica Butorphanol Product Portfolio Table 107. Animedica Recent Developments Table 108. Global Butorphanol Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Butorphanol Sales by Region (2021-2026) & (K Units) Table 110. Global Butorphanol Sales Market Share by Region (2021-2026) Table 111. Global Butorphanol Sales by Region (2027-2032) & (K Units) Table 112. Global Butorphanol Sales Market Share by Region (2027-2032) Table 113. Global Butorphanol Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Butorphanol Revenue Market Share by Region (2021-2026) Table 115. Global Butorphanol Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Butorphanol Revenue Market Share by Region (2027-2032) Table 117. North America Butorphanol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Butorphanol Sales by Country (2021-2026) & (K Units) Table 119. North America Butorphanol Sales by Country (2027-2032) & (K Units) Table 120. North America Butorphanol Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Butorphanol Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Butorphanol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Butorphanol Sales by Country (2021-2026) & (K Units) Table 124. Europe Butorphanol Sales by Country (2027-2032) & (K Units) Table 125. Europe Butorphanol Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Butorphanol Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Butorphanol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Butorphanol Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Butorphanol Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Butorphanol Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Butorphanol Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Butorphanol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Butorphanol Sales by Country (2021-2026) & (K Units) Table 134. South America Butorphanol Sales by Country (2027-2032) & (K Units) Table 135. South America Butorphanol Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Butorphanol Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Butorphanol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Butorphanol Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Butorphanol Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Butorphanol Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Butorphanol Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Butorphanol Sales by Type (2021-2026) & (K Units) Table 143. Global Butorphanol Sales by Type (2027-2032) & (K Units) Table 144. Global Butorphanol Sales Market Share by Type (2021-2026) Table 145. Global Butorphanol Sales Market Share by Type (2027-2032) Table 146. Global Butorphanol Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Butorphanol Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Butorphanol Revenue Market Share by Type (2021-2026) Table 149. Global Butorphanol Revenue Market Share by Type (2027-2032) Table 150. Global Butorphanol Price by Type (2021-2026) & (US$/Unit) Table 151. Global Butorphanol Price by Type (2027-2032) & (US$/Unit) Table 152. Global Butorphanol Sales by Application (2021-2026) & (K Units) Table 153. Global Butorphanol Sales by Application (2027-2032) & (K Units) Table 154. Global Butorphanol Sales Market Share by Application (2021-2026) Table 155. Global Butorphanol Sales Market Share by Application (2027-2032) Table 156. Global Butorphanol Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Butorphanol Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Butorphanol Revenue Market Share by Application (2021-2026) Table 159. Global Butorphanol Revenue Market Share by Application (2027-2032) Table 160. Global Butorphanol Price by Application (2021-2026) & (US$/Unit) Table 161. Global Butorphanol Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Butorphanol Distributors List Table 165. Butorphanol Customers List Table 166. Butorphanol Industry Trends Table 167. Butorphanol Industry Drivers Table 168. Butorphanol Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Butorphanol Product Image Figure 5. Global Butorphanol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Butorphanol Market Size (2021-2032) & (US$ Million) Figure 7. Global Butorphanol Sales (2021-2032) & (K Units) Figure 8. Global Butorphanol Average Price (US$/Unit) & (2021-2032) Figure 9. Injection Product Image Figure 10. Spray Product Image Figure 11. Tablet Product Image Figure 12. Human Product Image Figure 13. Veterinary Product Image Figure 14. Global Butorphanol Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Butorphanol, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Butorphanol Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Butorphanol Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Butorphanol Sales by Region in 2025 Figure 20. Global Butorphanol Revenue by Region in 2025 Figure 21. North America Butorphanol Market Size by Country in 2025 Figure 22. North America Butorphanol Sales Market Share by Country (2021-2032) Figure 23. North America Butorphanol Revenue Market Share by Country (2021-2032) Figure 24. United States Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Butorphanol Market Size by Country in 2025 Figure 27. Europe Butorphanol Sales Market Share by Country (2021-2032) Figure 28. Europe Butorphanol Revenue Market Share by Country (2021-2032) Figure 29. Germany Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Butorphanol Market Size by Country in 2025 Figure 35. Asia Pacific Butorphanol Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Butorphanol Revenue Market Share by Country (2021-2032) Figure 37. China Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Butorphanol Market Size by Country in 2025 Figure 46. South America Butorphanol Sales Market Share by Country (2021-2032) Figure 47. South America Butorphanol Revenue Market Share by Country (2021-2032) Figure 48. Mexico Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Butorphanol Market Size by Country in 2025 Figure 52. Middle East and Africa Butorphanol Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Butorphanol Revenue Market Share by Country (2021-2032) Figure 54. Turkey Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Butorphanol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Butorphanol Sales Market Share by Type (2021-2032) Figure 58. Global Butorphanol Revenue Market Share by Type (2021-2032) Figure 59. Global Butorphanol Price (US$/Unit) by Type (2021-2032) Figure 60. Global Butorphanol Sales Market Share by Application (2021-2032) Figure 61. Global Butorphanol Revenue Market Share by Application (2021-2032) Figure 62. Global Butorphanol Price (US$/Unit) by Application (2021-2032) Figure 63. Butorphanol Value Chain Figure 64. Butorphanol Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Butorphanol Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection
  • Spray
  • Tablet
Applications
  • Human
  • Veterinary
Companies covered
  • Zoetis
  • Merck KGaA
  • Mylan
  • Pfizer
  • Troy Laboratories Nz
  • Selectavet
  • Sanochemia Pharmazeutika
  • Richter Pharma Ag
  • Novex Pharma
  • Hikma Pharmaceuticals
  • Faunapharma
  • Dechra Pharmaceuticals
  • Bristol Myers Squibb
  • Boehringer Ingelheim Santé Animale
  • Ausrichter
  • Athanas Enterprise Private Limited
  • Apothecon Pharmaceuticals
  • Animedica

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Butorphanol Market Size (2021-2032)
  4. 2.2.2 Global Butorphanol Sales (2021-2032)
  5. 2.2.3 Global Butorphanol Market Average Price (2021-2032)
  6. 2.3 Butorphanol by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection
  9. 2.3.3 Spray
  10. 2.3.4 Tablet
  11. 2.4 Butorphanol by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Human
  14. 2.4.3 Veterinary
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Butorphanol Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Butorphanol Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Butorphanol Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Butorphanol Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Butorphanol Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Butorphanol, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Butorphanol, Product Type & Application
  8. 3.8 Global Manufacturers of Butorphanol, Established Date
  9. 3.9 Global Butorphanol Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Butorphanol Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Merck KGaA
  8. 4.2.1 Merck KGaA Company Information
  9. 4.2.2 Merck KGaA Business Overview
  10. 4.2.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck KGaA Butorphanol Product Portfolio
  12. 4.2.5 Merck KGaA Recent Developments
  13. 4.3 Mylan
  14. 4.3.1 Mylan Company Information
  15. 4.3.2 Mylan Business Overview
  16. 4.3.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Mylan Butorphanol Product Portfolio
  18. 4.3.5 Mylan Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Butorphanol Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Troy Laboratories Nz
  26. 4.5.1 Troy Laboratories Nz Company Information
  27. 4.5.2 Troy Laboratories Nz Business Overview
  28. 4.5.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Troy Laboratories Nz Butorphanol Product Portfolio
  30. 4.5.5 Troy Laboratories Nz Recent Developments
  31. 4.6 Selectavet
  32. 4.6.1 Selectavet Company Information
  33. 4.6.2 Selectavet Business Overview
  34. 4.6.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Selectavet Butorphanol Product Portfolio
  36. 4.6.5 Selectavet Recent Developments
  37. 4.7 Sanochemia Pharmazeutika
  38. 4.7.1 Sanochemia Pharmazeutika Company Information
  39. 4.7.2 Sanochemia Pharmazeutika Business Overview
  40. 4.7.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sanochemia Pharmazeutika Butorphanol Product Portfolio
  42. 4.7.5 Sanochemia Pharmazeutika Recent Developments
  43. 4.8 Richter Pharma Ag
  44. 4.8.1 Richter Pharma Ag Company Information
  45. 4.8.2 Richter Pharma Ag Business Overview
  46. 4.8.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Richter Pharma Ag Butorphanol Product Portfolio
  48. 4.8.5 Richter Pharma Ag Recent Developments
  49. 4.9 Novex Pharma
  50. 4.9.1 Novex Pharma Company Information
  51. 4.9.2 Novex Pharma Business Overview
  52. 4.9.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Novex Pharma Butorphanol Product Portfolio
  54. 4.9.5 Novex Pharma Recent Developments
  55. 4.10 Hikma Pharmaceuticals
  56. 4.10.1 Hikma Pharmaceuticals Company Information
  57. 4.10.2 Hikma Pharmaceuticals Business Overview
  58. 4.10.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hikma Pharmaceuticals Butorphanol Product Portfolio
  60. 4.10.5 Hikma Pharmaceuticals Recent Developments
  61. 4.11 Faunapharma
  62. 4.11.1 Faunapharma Company Information
  63. 4.11.2 Faunapharma Business Overview
  64. 4.11.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Faunapharma Butorphanol Product Portfolio
  66. 4.11.5 Faunapharma Recent Developments
  67. 4.12 Dechra Pharmaceuticals
  68. 4.12.1 Dechra Pharmaceuticals Company Information
  69. 4.12.2 Dechra Pharmaceuticals Business Overview
  70. 4.12.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dechra Pharmaceuticals Butorphanol Product Portfolio
  72. 4.12.5 Dechra Pharmaceuticals Recent Developments
  73. 4.13 Bristol Myers Squibb
  74. 4.13.1 Bristol Myers Squibb Company Information
  75. 4.13.2 Bristol Myers Squibb Business Overview
  76. 4.13.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bristol Myers Squibb Butorphanol Product Portfolio
  78. 4.13.5 Bristol Myers Squibb Recent Developments
  79. 4.14 Boehringer Ingelheim Santé Animale
  80. 4.14.1 Boehringer Ingelheim Santé Animale Company Information
  81. 4.14.2 Boehringer Ingelheim Santé Animale Business Overview
  82. 4.14.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio
  84. 4.14.5 Boehringer Ingelheim Santé Animale Recent Developments
  85. 4.15 Ausrichter
  86. 4.15.1 Ausrichter Company Information
  87. 4.15.2 Ausrichter Business Overview
  88. 4.15.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Ausrichter Butorphanol Product Portfolio
  90. 4.15.5 Ausrichter Recent Developments
  91. 4.16 Athanas Enterprise Private Limited
  92. 4.16.1 Athanas Enterprise Private Limited Company Information
  93. 4.16.2 Athanas Enterprise Private Limited Business Overview
  94. 4.16.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Athanas Enterprise Private Limited Butorphanol Product Portfolio
  96. 4.16.5 Athanas Enterprise Private Limited Recent Developments
  97. 4.17 Apothecon Pharmaceuticals
  98. 4.17.1 Apothecon Pharmaceuticals Company Information
  99. 4.17.2 Apothecon Pharmaceuticals Business Overview
  100. 4.17.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Apothecon Pharmaceuticals Butorphanol Product Portfolio
  102. 4.17.5 Apothecon Pharmaceuticals Recent Developments
  103. 4.18 Animedica
  104. 4.18.1 Animedica Company Information
  105. 4.18.2 Animedica Business Overview
  106. 4.18.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Animedica Butorphanol Product Portfolio
  108. 4.18.5 Animedica Recent Developments
5 Global Butorphanol Market Scenario by Region
  1. 5.1 Global Butorphanol Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Butorphanol Sales by Region: 2021-2032
  3. 5.2.1 Global Butorphanol Sales by Region: 2021-2026
  4. 5.2.2 Global Butorphanol Sales by Region: 2027-2032
  5. 5.3 Global Butorphanol Revenue by Region: 2021-2032
  6. 5.3.1 Global Butorphanol Revenue by Region: 2021-2026
  7. 5.3.2 Global Butorphanol Revenue by Region: 2027-2032
  8. 5.4 North America Butorphanol Market Facts & Figures by Country
  9. 5.4.1 North America Butorphanol Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Butorphanol Sales by Country (2021-2032)
  11. 5.4.3 North America Butorphanol Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Butorphanol Market Facts & Figures by Country
  15. 5.5.1 Europe Butorphanol Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Butorphanol Sales by Country (2021-2032)
  17. 5.5.3 Europe Butorphanol Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Butorphanol Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Butorphanol Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Butorphanol Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Butorphanol Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Butorphanol Market Facts & Figures by Country
  35. 5.7.1 South America Butorphanol Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Butorphanol Sales by Country (2021-2032)
  37. 5.7.3 South America Butorphanol Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Butorphanol Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Butorphanol Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Butorphanol Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Butorphanol Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Butorphanol Sales by Type (2021-2032)
  2. 6.1.1 Global Butorphanol Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Butorphanol Sales Market Share by Type (2021-2032)
  4. 6.2 Global Butorphanol Revenue by Type (2021-2032)
  5. 6.2.1 Global Butorphanol Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Butorphanol Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Butorphanol Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Butorphanol Sales by Application (2021-2032)
  2. 7.1.1 Global Butorphanol Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Butorphanol Sales Market Share by Application (2021-2032)
  4. 7.2 Global Butorphanol Revenue by Application (2021-2032)
  5. 7.2.1 Global Butorphanol Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Butorphanol Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Butorphanol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Butorphanol Value Chain Analysis
  2. 8.1.1 Butorphanol Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Butorphanol Production Mode & Process
  5. 8.2 Butorphanol Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Butorphanol Distributors
  8. 8.2.3 Butorphanol Customers
9 Global Butorphanol Analyzing Market Dynamics
  1. 9.1 Butorphanol Industry Trends
  2. 9.2 Butorphanol Industry Drivers
  3. 9.3 Butorphanol Industry Opportunities and Challenges
  4. 9.4 Butorphanol Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst